Insulin Glargine (U-300) Pens and Vabomere Injection
Determining the interaction of Insulin Glargine (U-300) Pens and Vabomere Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: meropenem / vaborbactam
Brand name: Vabomere
Synonyms: Meropenem and vaborbactam, Meropenem and Vaborbactam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-300) Pens-Vaccinia
- Insulin Glargine (U-300) Pens-Vaccinia Immune Globulin (Intravenous)
- Insulin Glargine (U-300) Pens-Vaccinia immune globulin, human Intravenous
- Insulin Glargine (U-300) Pens-VacuStim Black
- Insulin Glargine (U-300) Pens-VacuStim Wound Therapy Kit
- Insulin Glargine (U-300) Pens-Vagifem
- Vabomere Injection-Insulin glargine and lixisenatide
- Vabomere Injection-Insulin glargine and lixisenatide Subcutaneous
- Vabomere Injection-Insulin glargine, recombinant Subcutaneous
- Vabomere Injection-Insulin glulisine
- Vabomere Injection-Insulin Glulisine (Cartridges and Pens)
- Vabomere Injection-Insulin Glulisine (Vials)